Literature DB >> 29270820

Stem Cell Transplantation and Physical Exercise in Parkinson's Disease, a Literature Review of Human and Animal Studies.

Jaison Daniel Cucarián Hurtado1,2, Jenny Paola Berrío Sánchez3, Ramiro Barcos Nunes4, Alcyr Alves de Oliveira3.   

Abstract

The absence of effective and satisfactory treatments that contribute to repairing the dopaminergic damage caused by Parkinson's Disease (PD) and the limited recovery capacity of the nervous system are troubling issues and the focus of many research and clinical domains. Recent advances in the treatment of PD through stem cell (SC) therapy have recognized their promising restorative and neuroprotective effects that are implicated in the potentiation of endogenous mechanisms of repair and contribute to functional locomotor improvement. Physical exercise (PE) has been considered an adjuvant intervention that by itself induces beneficial effects in patients and animal models with Parkinsonism. In this sense, the combination of both therapies could provide synergic or superior effects for motor recovery, in contrast with their individual use. This review aims to provide an update on recent progress and the potential effectiveness of SC transplantation and PE for the treatment of locomotor deficits in PD. It has reviewed the neuropathological pathways involved in the classical motor symptoms of this condition and the mechanisms of action described in experimental studies that are associated with locomotor enhancement through exercise, cellular transplantation, and their union in some neurodegenerative conditions.

Entities:  

Keywords:  Cell replacement; Neurodegenerative diseases and disease-modifying therapies; Parkinson’s disease; Physical activity; Physical exercise; Stem cell transplantation

Mesh:

Year:  2018        PMID: 29270820     DOI: 10.1007/s12015-017-9798-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  101 in total

Review 1.  Skeletal muscle mitochondria: a major player in exercise, health and disease.

Authors:  Aaron P Russell; Victoria C Foletta; Rod J Snow; Glenn D Wadley
Journal:  Biochim Biophys Acta       Date:  2013-11-27

2.  Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration.

Authors:  Yuen-Sum Lau; Gaurav Patki; Kaberi Das-Panja; Wei-Dong Le; S Omar Ahmad
Journal:  Eur J Neurosci       Date:  2011-03-07       Impact factor: 3.386

3.  Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.

Authors:  Gabriele Mittermeyer; Chadwick W Christine; Kathryn H Rosenbluth; Suzanne L Baker; Philip Starr; Paul Larson; Paul L Kaplan; John Forsayeth; Michael J Aminoff; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2012-04-10       Impact factor: 5.695

Review 4.  The beneficial role of intensive exercise on Parkinson disease progression.

Authors:  Giuseppe Frazzitta; Pietro Balbi; Roberto Maestri; Gabriella Bertotti; Natalia Boveri; Gianni Pezzoli
Journal:  Am J Phys Med Rehabil       Date:  2013-06       Impact factor: 2.159

Review 5.  Effects of resistance training on cytokines.

Authors:  B F de Salles; R Simão; S J Fleck; I Dias; L G Kraemer-Aguiar; E Bouskela
Journal:  Int J Sports Med       Date:  2010-04-29       Impact factor: 3.118

Review 6.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

7.  Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.

Authors:  Neelam K Venkataramana; Satish K V Kumar; Sudheer Balaraju; Radhika Chemmangattu Radhakrishnan; Abhilash Bansal; Ashish Dixit; Deepthi K Rao; Madhulita Das; Majahar Jan; Pawan Kumar Gupta; Satish M Totey
Journal:  Transl Res       Date:  2009-08-06       Impact factor: 7.012

Review 8.  Is there muscular weakness in Parkinson's disease?

Authors:  Roberto Cano-de-la-Cuerda; Marta Pérez-de-Heredia; Juan Carlos Miangolarra-Page; Elena Muñoz-Hellín; Cesar Fernández-de-Las-Peñas
Journal:  Am J Phys Med Rehabil       Date:  2010-01       Impact factor: 2.159

9.  Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.

Authors:  Shin-Ichi Muramatsu; Tsuyoshi Okuno; Yutaka Suzuki; Takashi Nakayama; Takeharu Kakiuchi; Naomi Takino; Asako Iida; Fumiko Ono; Keiji Terao; Nobuo Inoue; Imaharu Nakano; Yasushi Kondo; Hideo Tsukada
Journal:  Synapse       Date:  2009-07       Impact factor: 2.562

Review 10.  PPARγ and PGC-1α as therapeutic targets in Parkinson's.

Authors:  Juan Carlos Corona; Michael R Duchen
Journal:  Neurochem Res       Date:  2014-07-10       Impact factor: 3.996

View more
  1 in total

1.  A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson's Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity.

Authors:  Jea-Young Lee; Julian P Tuazon; Sydney Corey; Brooke Bonsack; Sandra Acosta; Jared Ehrhart; Paul R Sanberg; Cesario V Borlongan
Journal:  Stem Cell Rev Rep       Date:  2019-10       Impact factor: 6.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.